Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

58

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Immunotherapy for glioblastoma and its microenvironment

Related Posts

A b-hydroxybutyrate shunt pathway generates anti- obesity ketone metabolites

A b-hydroxybutyrate shunt pathway generates anti- obesi...

49

Multitissue single-cell analysis reveals differential cellular and molecular sensitivity between fructose and high-fat high-sucrose diets

Multitissue single-cell analysis reveals differential c...

108

Rest and rinse: sleeping rhythms drive brain detox

Rest and rinse: sleeping rhythms drive brain detox

96